A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation
Background & Aims: Human allogeneic liver-derived progenitor cells (HALPC, HepaStem®; Promethera Biosciences, Mont-Saint-Guibert, Belgium) are an advanced therapy medicinal product that could potentially alleviate systemic inflammation and ameliorate liver function in patients with acute-on-...
Main Authors: | Frederik Nevens, Thierry Gustot, Pierre-François Laterre, Luc L. Lasser, Lyudmil E. Haralampiev, Victor Vargas, Desislava Lyubomirova, Agustin Albillos, Mustapha Najimi, Sébastien Michel, Ivaylo Stoykov, Noelia Gordillo, Yelena Vainilovich, Virginie Barthel, Nathalie Clerget-Chossat, Etienne M. Sokal |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555921000677 |
Similar Items
-
Acute (Not Decompensation)-on-Chronic Liver Failure
by: Cilénia Baldaia
Published: (2017-12-01) -
Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival
by: Annarein J. C. Kerbert, et al.
Published: (2017-12-01) -
Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
by: Michael Nagel, et al.
Published: (2020-01-01) -
Acute-on-chronic liver failure
by: Tae Yeob Kim, et al.
Published: (2013-12-01) -
Percutaneous shunt reduction for the management of TIPS-induced acute liver decompensation: A follow-up study
by: Bart De Keyzer, et al.
Published: (2016-11-01)